1. Home
  2. QURE vs WSR Comparison

QURE vs WSR Comparison

Compare QURE & WSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • WSR
  • Stock Information
  • Founded
  • QURE 1998
  • WSR 1998
  • Country
  • QURE Netherlands
  • WSR United States
  • Employees
  • QURE N/A
  • WSR N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • WSR Real Estate Investment Trusts
  • Sector
  • QURE Health Care
  • WSR Real Estate
  • Exchange
  • QURE Nasdaq
  • WSR Nasdaq
  • Market Cap
  • QURE 725.4M
  • WSR 628.6M
  • IPO Year
  • QURE 2007
  • WSR 2010
  • Fundamental
  • Price
  • QURE $17.27
  • WSR $12.30
  • Analyst Decision
  • QURE Strong Buy
  • WSR Strong Buy
  • Analyst Count
  • QURE 10
  • WSR 2
  • Target Price
  • QURE $37.20
  • WSR $15.00
  • AVG Volume (30 Days)
  • QURE 1.4M
  • WSR 216.4K
  • Earning Date
  • QURE 07-31-2025
  • WSR 07-30-2025
  • Dividend Yield
  • QURE N/A
  • WSR 4.21%
  • EPS Growth
  • QURE N/A
  • WSR 26.93
  • EPS
  • QURE N/A
  • WSR 0.61
  • Revenue
  • QURE $20,201,000.00
  • WSR $155,128,000.00
  • Revenue This Year
  • QURE $27.16
  • WSR $1.46
  • Revenue Next Year
  • QURE $248.21
  • WSR $4.57
  • P/E Ratio
  • QURE N/A
  • WSR $20.18
  • Revenue Growth
  • QURE 6.30
  • WSR 6.69
  • 52 Week Low
  • QURE $3.73
  • WSR $11.78
  • 52 Week High
  • QURE $19.18
  • WSR $15.36
  • Technical
  • Relative Strength Index (RSI)
  • QURE 67.53
  • WSR 43.04
  • Support Level
  • QURE $14.75
  • WSR $12.07
  • Resistance Level
  • QURE $15.50
  • WSR $12.41
  • Average True Range (ATR)
  • QURE 1.07
  • WSR 0.22
  • MACD
  • QURE 0.16
  • WSR 0.03
  • Stochastic Oscillator
  • QURE 93.40
  • WSR 46.58

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

Share on Social Networks: